DavidFitz-PatrickMD

Clinical Trials

• A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus Start of enrollment: 2014 Apr 01

  Terminated

  Phase 2

• A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes Start of enrollment: 2014 Apr 01

  Completed

  Phase 2

• A Safety and Immunogenicity Phase IC Study of CryJ2 -DNA-LAMP Plasmid Vaccine for Assessment of Intradermal (ID) Route of Administration Using the Biojector 2000 Device Start of enrollment: 2014 Jun 01

  Completed

  Phase 1

• A Study of LY2623091 in Participants With High Blood Pressure Start of enrollment: 2014 Aug 01

  Completed

  Phase 2

• A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol Start of enrollment: 2014 Oct 01

  Terminated

  Phase 3

• A Study of Investigational Dulaglutide Doses in Participants With Type 2 Diabetes on Metformin Monotherapy Start of enrollment: 2016 Dec 01

  Completed

  Phase 2

• Comparative User Experiences With BD Nano™ PRO 4mm x 32G Extra Thin Wall Pen Needle vs Three Commercially Available Pen Needles Start of enrollment: 2019 Feb 07

  Completed

  Not Applicable

• A Clinical Trial to Evaluate the Safety and Immunogenicity of rVSV∆G-LASV-GPC Vaccine in Adults in Good General Heath Start of enrollment: 2021 Jun 23

  Active, not recruiting

  Phase 1

  Roles: Contact

• A Registry for Participants With Chronic Hypoparathyroidism Start of enrollment: 2013 Jul 30

  Active, not recruiting

  Roles: Principal Investigator

• Join now to see all